Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
Dyne Therapeutics, Inc. (Nasdaq: DYN) announced that key executives will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium. The event will be live-streamed and a replay will be available for 90 days.
03/27/2024 - 08:30 AM
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc
A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations
About Dyne Therapeutics
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/ X LinkedIn Facebook
Contact:
Dyne Therapeuticsareilly@dyne-tx.com
When is Dyne Therapeutics' fireside chat at the Cantor Virtual Muscular Dystrophy Symposium scheduled?
Dyne Therapeutics' fireside chat at the Cantor Virtual Muscular Dystrophy Symposium is scheduled for Tuesday, April 2, 2024, at 9:50 a.m. ET.
Where can investors watch the live webcast of the fireside chat?
Investors can watch the live webcast of the fireside chat in the Investors & Media section of Dyne's website at https://investors.dyne-tx.com/news-and-events/events-and-presentations.
How long will the replay of the fireside chat be accessible?
The replay of the fireside chat will be accessible for 90 days following the presentation.
Dyne Therapeutics Inc
NASDAQ:DYN
DYN Rankings
#4413 Ranked by Stock Gains
DYN Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Commercial Services, Miscellaneous Commercial Services, Health Technology, Biotechnology
Country
US
City
Waltham
About DYN
dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.
